Free Trial

Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Nicholas Investment Partners LP

Axon Enterprise logo with Industrial Products background

Nicholas Investment Partners LP boosted its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 76.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,054 shares of the biotechnology company's stock after purchasing an additional 1,319 shares during the period. Nicholas Investment Partners LP's holdings in Axon Enterprise were worth $899,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the business. 9258 Wealth Management LLC bought a new stake in Axon Enterprise during the 4th quarter valued at about $204,000. Principal Securities Inc. bought a new position in Axon Enterprise in the fourth quarter worth approximately $49,000. Envestnet Portfolio Solutions Inc. increased its holdings in Axon Enterprise by 1.1% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company's stock worth $1,033,000 after purchasing an additional 43 shares during the period. Principal Financial Group Inc. raised its position in Axon Enterprise by 14.4% during the 4th quarter. Principal Financial Group Inc. now owns 99,556 shares of the biotechnology company's stock valued at $25,718,000 after purchasing an additional 12,544 shares in the last quarter. Finally, Ieq Capital LLC lifted its holdings in shares of Axon Enterprise by 101.0% in the 4th quarter. Ieq Capital LLC now owns 3,172 shares of the biotechnology company's stock worth $819,000 after buying an additional 1,594 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.


Analyst Ratings Changes

Several analysts recently weighed in on AXON shares. Northland Securities lifted their price objective on Axon Enterprise from $330.00 to $365.00 and gave the company an "outperform" rating in a report on Thursday, August 8th. Craig Hallum upped their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research report on Wednesday, August 7th. Barclays lifted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Needham & Company LLC restated a "buy" rating and set a $400.00 target price on shares of Axon Enterprise in a report on Wednesday, August 7th. Finally, Robert W. Baird lifted their price target on Axon Enterprise from $360.00 to $400.00 and gave the company an "outperform" rating in a report on Tuesday. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $365.38.

Read Our Latest Stock Report on Axon Enterprise

Axon Enterprise Stock Performance

AXON stock traded down $4.90 during trading on Friday, reaching $379.61. The company had a trading volume of 506,476 shares, compared to its average volume of 520,816. The company has a market cap of $28.69 billion, a price-to-earnings ratio of 111.00, a price-to-earnings-growth ratio of 9.69 and a beta of 0.94. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $385.00. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The firm has a 50-day simple moving average of $338.92 and a 200-day simple moving average of $314.35.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business's revenue for the quarter was up 34.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.80 earnings per share. As a group, sell-side analysts expect that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Insider Activity

In other news, CEO Patrick W. Smith sold 80,300 shares of the company's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares of the company's stock, valued at approximately $1,121,052,771.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Axon Enterprise news, CEO Patrick W. Smith sold 75,000 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $356.53, for a total value of $26,739,750.00. Following the completion of the transaction, the chief executive officer now directly owns 2,970,366 shares of the company's stock, valued at $1,059,024,589.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 316,981 shares of company stock valued at $115,281,744. Company insiders own 6.10% of the company's stock.

Axon Enterprise Company Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

→ Forget Trump and Kamala (From Investors Alley) (Ad)

Should you invest $1,000 in Axon Enterprise right now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Is Palantir Heading for a $50 Price Target?
Rate Cuts Fuel Volatility: How Long Could it Last?
SMCI Stock: Is a Rebound Coming?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines